YES:TSXVChar Technologies Ltd. Analysis
Data as of 2026-05-14 - not real-time
₹22.19
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Yes Bank is trading at INR 22.19, comfortably above its 20‑day SMA (20.84) and 50‑day SMA (19.70) but just below the 200‑day SMA (20.99), indicating short‑term strength within a neutral longer‑term trend. The RSI sits at 66.6, signaling the stock is approaching overbought territory, while a bullish MACD histogram (+0.17) and increasing volume suggest continued upward momentum toward the resistance level of INR 23.18. However, the 30‑day volatility is high at 33.8% and the beta of 0.43 points to limited market‑wide sensitivity, meaning price swings are largely driven by company‑specific factors. Valuation metrics show a trailing P/E of 19.8, notably higher than the industry average of 16.4, and an upside/downside estimate of –12.9%, implying the market may be pricing in overvaluation despite a more attractive forward P/E of 12.6. Fundamentally, revenue grew 19.8% YoY with a strong operating margin of 54.7% and profit margin of 22.0%, yet operating cash flow remains deeply negative, raising concerns about cash generation.
The upcoming Q4 results are expected to deliver a 16% YoY jump in Net Interest Income and a profit increase of 4‑44%, which could bolster sentiment, especially as analysts have flagged a "buy" recommendation post‑earnings. Nevertheless, analyst price targets average INR 19.3, below the current price, and the stock’s dividend sustainability is nil. With an extreme greed sentiment (FGI 89.5) and a modest upside, the balance of technical vigor, valuation stretch, and cash‑flow weakness suggests a cautious stance pending the earnings release.
The upcoming Q4 results are expected to deliver a 16% YoY jump in Net Interest Income and a profit increase of 4‑44%, which could bolster sentiment, especially as analysts have flagged a "buy" recommendation post‑earnings. Nevertheless, analyst price targets average INR 19.3, below the current price, and the stock’s dividend sustainability is nil. With an extreme greed sentiment (FGI 89.5) and a modest upside, the balance of technical vigor, valuation stretch, and cash‑flow weakness suggests a cautious stance pending the earnings release.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD and rising volume
- RSI near overbought levels
- Current price near resistance with limited upside
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong revenue and margin growth
- Negative operating cash flow
- Valuation above industry peers
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Robust revenue growth and low leverage
- Potential earnings upside from Q4 NII expansion
- Improving forward P/E relative to current valuation
Key Metrics & Analysis
Financial Health
Revenue Growth19.80%
Profit Margin22.05%
P/E Ratio19.8
ROE7.09%
ROA0.79%
P/B Ratio1.4
Op. Cash Flow₹-133323497472
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI66.6
Support₹19.67
Resistance₹23.18
MA 20₹20.84
MA 50₹19.70
MA 200₹20.99
MACDBullish
VolumeIncreasing
Fear & Greed Index89.5
Valuation
Target Price₹19.32
Upside/Downside-12.94%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.43
Volatility33.81%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.